Personal information

Countries

United Kingdom

Activities

Collapse all

Employment (4)

Oxford University Hospitals NHS Trust: Oxford, Oxfordshire, GB

2013-04-23 to present | Senior Clinical Scientist (Transplant Immunology)
Employment
Source: Self-asserted source
Mian Chen

Oxford University Hospitals NHS Trust: Oxford, Oxfordshire, GB

2006-06-08 to 2013-04-22 | Clinical Scientist (Oxford Transplant Centre)
Employment
Source: Self-asserted source
Mian Chen

National Blood Service - Tooting: London, London, GB

2003-11-03 to 2006-05-08 | Trainee Scientist (Histocompatibility and Immunogenetics)
Employment
Source: Self-asserted source
Mian Chen

Southern Medical University Nanfang Hospital: Guangzhou, Guangdong, CN

2001-06-01 to 2002-07-01 | House Officer
Employment
Source: Self-asserted source
Mian Chen

Education and qualifications (5)

Royal College of Pathologists: London, London, GB

2019-05-23 to present | FRCPath Part II in Histocompatibility and Immunogenetics
Qualification
Source: Self-asserted source
Mian Chen

Royal College of Pathologists: London, London, GB

2015-01-01 to present | FRCPath Part I in Histocompatibility and Immunogenetics
Education
Source: Self-asserted source
Mian Chen

British Society for Histocompatibility and Immunogenetics: London, London, GB

2004-01-01 to 2006-09-01 | BSHI Diploma
Education
Source: Self-asserted source
Mian Chen

University of Nottingham: Nottingham, Nottingham, GB

2002-09-18 to 2003-09-18 | MSc in Immunology (School of Life Sciences)
Education
Source: Self-asserted source
Mian Chen

First Military Medical University (Southern Medical University): Guangzhou, Guangdong, CN

1997-09-01 to 2002-07-01 | MBBS (Clinical Medicine)
Education
Source: Self-asserted source
Mian Chen

Professional activities (3)

British Society for Histocompatibility and Immunogenetics: London, London, GB

2018-12-16 to present | Treasurer
Service
Source: Self-asserted source
Mian Chen

British Society for Histocompatibility and Immunogenetics: London, London, GB

2003-11-03 to present | Member
Membership
Source: Self-asserted source
Mian Chen

British Society for Histocompatibility and Immunogenetics: London, London, GB

2013-11-22 to 2019-06-20 | Research Executive
Service
Source: Self-asserted source
Mian Chen

Works (15)

Towards uniformity in the definition of acceptable mismatches for highly sensitized patients

HLA
2019-08 | Journal article
DOI: 10.1111/tan.13607
Contributors: Mian Chen; Yvonne Zoet; Dave Roelen; Jaume Martorell; Derek Middleton; Antonij Slavcev; Aliki Iniotaki; Frans Claas; Susan Fuggle
Source: check_circle
Crossref

Distinct HLA associations of LGI1 and CASPR2-antibody diseases

Brain
2018-08-01 | Journal article
DOI: 10.1093/brain/awy109
Part of ISSN: 0006-8950
Part of ISSN: 1460-2156
Source: Self-asserted source
Mian Chen

De novo donor-specific HLA antibodies after combined intestinal and vascularized composite allotransplantation - a retrospective study

Transplant International
2018-04 | Journal article
DOI: 10.1111/tri.13096
Part of ISSN: 0934-0874
Source: Self-asserted source
Mian Chen

Belatacept and Basiliximab in Intestinal Transplantation

Transplantation
2017-06 | Journal article
DOI: 10.1097/01.tp.0000521282.83986.56
Contributors: Georgios Vrakas; Annemarie Weissenbacher; Mian Chen; Philip Allan; Alison Smith; Karen Turkmen; Lydia Holdaway; Susan Fuggle; Srikanth Reddy; Peter Friend
Source: Self-asserted source
Mian Chen via Crossref Metadata Search

Donor Specific HLA Antibodies After Combined Intestinal and Vascularised Composite Allotransplantation

Transplantation
2017-06 | Journal article
DOI: 10.1097/01.tp.0000521277.30621.96
Contributors: Annemarie Weissenbacher; Georgios Vrakas; Mian Chen; Martin Barnardo; Srikanth Reddy; Peter Friend; Susan Fuggle
Source: Self-asserted source
Mian Chen via Crossref Metadata Search

Third-Party Mesenchymal Stromal Cell Therapy and Risk of Allosensitisation in Transplant Patients

Transplantation
2017-06 | Journal article
DOI: 10.1097/01.tp.0000521372.38726.8b
Contributors: Srikanth Reddy; Georgios Vrakas; Mian Chen; Martin Barnardo; Philip Allan; Franscesco Dazzi; Peter Friend; Susan Fuggle
Source: Self-asserted source
Mian Chen via Crossref Metadata Search

Application of Operational Tolerance Signatures Are Limited by Variability and Type of Immunosuppression in Renal Transplant Recipients: A Cross-Sectional Study.

Transplantation direct
2017-01 | Journal article
DOI: 10.1097/txd.0000000000000638
PMID: 28349125
PMC: PMC5361564
Source: Self-asserted source
Mian Chen via Europe PubMed Central

2519: Development of de novo donor-specific HLA antibodies after combined intestinal and vascularized composite allotransplantation

Vascularized Composite Allotransplantation
2016-10-10 | Journal article
DOI: 10.1080/23723505.2016.1232937
Contributors: Annemarie Weissenbacher; Georgios Vrakas; Mian Chen; Srikanth Reddy; Susan Fuggle; Peter Friend
Source: Self-asserted source
Mian Chen via Crossref Metadata Search

B-Cell populations and signatures of operational tolerance are markedly affected by immunosuppression in long-term renal transplant recipients

2016-02-24 | Conference abstract
Source: Self-asserted source
Mian Chen

HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants.

2014-10 | Journal article
DOI: 10.1038/ng.3093
PMID: 25217962
Contributors: Heap GA; Weedon MN; Bewshea CM; Singh A; Chen M; Satchwell JB; Vivian JP; So K; Dubois PC; Andrews JM et al.
Source: Self-asserted source
Mian Chen via Europe PubMed Central

Vessel rejection secondary to human leucocyte antigen antibodies directed against the arterial conduit following pancreas transplantation from a separate donor.

2014-07 | Journal article
DOI: 10.1111/tri.12308
PMID: 24617346
Contributors: Mittal S; Page S; Chen M; Procter J; Gilbert J; Sharples E; Friend P; Fuggle S
Source: Self-asserted source
Mian Chen via Europe PubMed Central

Impact of de novo HLA antibodies on retransplantation and outcome following islet transplant alone

2014-02-26 | Conference abstract
Source: Self-asserted source
Mian Chen

Isolated small bowel transplantation: application of risk stratification in the sensitised patient

International Journal of Immunogenetics
2013-09-04 | Conference abstract
Part of DOI: 10.1111/iji.12083
Source: Self-asserted source
Mian Chen

Prediction of CDC positivity using Luminex single antigen beads: EDTA-treated sera versus C1q assay

International Journal of Immunogenetics
2013-09-04 | Conference abstract
Part of DOI: 10.1111/iji.12083
Source: Self-asserted source
Mian Chen

Discovery of [1,2,4]triazolo[4,3-a]pyridines as potent Smoothened inhibitors targeting the Hedgehog pathway with improved antitumor activity in vivo

Journal article
DOI: 10.1016/j.bmc.2020.115584
Source: Self-asserted source
Mian Chen
How many people are using ORCID?